TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
-14.8%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$494M
AUM Growth
+$494M
(-0.63%)
Cap. Flow
+$130M
Cap. Flow
% of AUM
26.37%
Top 10 Holdings %
Top 10 Hldgs %
58.44%
Holding
58
New
29
Increased
5
Reduced
6
Closed
7
Top Buys
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$42.8M |
| 2 |
Bio-Rad Laboratories Class A
BIO
|
$22.5M |
| 3 |
Galapagos
GLPG
|
$15.5M |
| 4 |
Harmony Biosciences
HRMY
|
$14.6M |
| 5 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$14M |
Top Sells
| 1 |
Heron Therapeutics
HRTX
|
$23.2M |
| 2 |
Rocket Pharmaceuticals
RCKT
|
$20.1M |
| 3 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$18.2M |
| 4 |
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
|
$17.2M |
| 5 |
ANI Pharmaceuticals
ANIP
|
$5.62M |
Sector Composition
| 1 | Healthcare | 96.61% |
| 2 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
AnaptysBio
ANAB
$569M
| $65M | 13.01% | 2,628,678 | – | – |
|
|
ITCI
2
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $42.8M | 8.57% | +700,000 | New | +$42.8M |
|
|
LJPC
3
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $41M | 8.21% | 9,607,934 | – | – |
|
4
iTeos Therapeutics
ITOS
| $30.2M | 6.04% | 937,500 | – | – |
|
|
5
Bio-Rad Laboratories Class A
BIO
$8.06B
| $22.5M | 4.51% | +40,000 | New | +$22.5M |
|
|
6
Heron Therapeutics
HRTX
$207M
| $21.3M | 4.26% | 3,720,000 -4,062,928 | -52% | -$23.2M |
|
|
7
Rocket Pharmaceuticals
RCKT
$354M
| $20.1M | 4.02% | 1,265,900 -1,265,900 | -50% | -$20.1M |
|
8
Altimmune
ALT
$338M
| $15.7M | 3.14% | 2,573,744 +973,744 | +61% | +$5.93M |
|
|
9
Galapagos
GLPG
$2.07B
| $15.5M | 3.1% | +250,000 | New | +$15.5M |
|
|
10
Harmony Biosciences
HRMY
$2.12B
| $14.6M | 2.92% | +300,000 | New | +$14.6M |
|
|
ALBO
11
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $14M | 2.79% | +467,702 | New | +$14M |
|
12
Immunocore
IMCR
$1.62B
| $11.5M | 2.31% | +385,600 | New | +$11.5M |
|
13
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $9.68M | 1.94% | 750,000 +100,000 | +15% | +$1.29M |
|
|
SRRA
14
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $9.62M | 1.92% | +300,000 | New | +$9.62M |
|
15
KalVista Pharmaceuticals
KALV
$678M
| $9.56M | 1.91% | +648,269 | New | +$9.56M |
|
16
Inspirato
ISPO
$37.4M
| $8.5M | 1.7% | +855,368 | New | +$8.5M |
|
|
TCRR
17
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $8.28M | 1.66% | +3,000,000 | New | +$8.28M |
|
|
ALLK
18
DELISTED
Allakos
ALLK
| $7.54M | 1.51% | 1,323,393 | – | – |
|
|
BLUE
19
DELISTED
bluebird bio
BLUE
| $7.52M | 1.5% | +1,550,000 | New | +$7.52M |
|
20
Ionis Pharmaceuticals
IONS
$6.79B
| $7.41M | 1.48% | +200,000 | New | +$7.41M |
|
|
IMGN
21
DELISTED
Immunogen Inc
IMGN
| $7.14M | 1.43% | 1,500,000 | – | – |
|
22
Enanta Pharmaceuticals
ENTA
$180M
| $7.12M | 1.42% | +100,000 | New | +$7.12M |
|
23
BioNTech
BNTX
$24B
| $6.82M | 1.36% | +40,000 | New | +$6.82M |
|
24
Arcus Biosciences
RCUS
$1.13B
| $6.31M | 1.26% | +200,000 | New | +$6.31M |
|
|
ATYR
25
aTyr Pharma
ATYR
$527M
| $5.96M | 1.19% | 1,113,453 | – | – |
|